Olive Oil and Cancer: What Scientific Research Really Says

Olive Oil and Cancer: What Scientific Research Really Says

Cancer remains one of the world’s leading causes of death, responsible for nearly 1 in 6 deaths globally. While genetics and certain infections play a role, lifestyle and nutrition account for a substantial share of risk – meaning what we eat can move the needle in meaningful ways (1). The Mediterranean diet – rich in vegetables, legumes, fish, and especially extra virgin olive oil (EVOO) – has consistently been linked to lower rates of chronic disease and certain cancers (2).

Zooming in on olive oil itself, two significant scientific studies stand out. A meta-analysis of observational studies found people in the highest olive oil intake group had lower odds of any cancer, with particularly strong signals for breast and digestive cancers (3). And in two landmark U.S. cohorts (over 92,000 adults followed through 2018), those consuming more olive oil had lower mortality from cardiovascular disease, cancer, neurodegenerative, and respiratory causes; importantly, swapping 10 g/day of butter, margarine, mayonnaise, or dairy fat for olive oil was associated with 8–34% lower risk of total and cause-specific mortality (4).

So what inside olive oil might be protective – and how do we use that knowledge in day-to-day life?

Meet the “Active” Part of Olive Oil

EVOO is mostly heart-healthy monounsaturated fat (oleic acid), but 1–2% is made up of bioactive molecules – polyphenols (like oleocanthal, oleacein, hydroxytyrosol), lignans, tocopherols, phytosterols, and squalene – that appear to drive many of its health benefits (5).

The European Food Safety Authority (EFSA) even authorizes a health claim for olive oil polyphenols protecting LDL from oxidation at intakes providing 5 mg/day of hydroxytyrosol and related compounds, an amount typically met with about 20 g (~1.5 Tbsp) of high-phenolic EVOO (6).

A quick sensory clue that your EVOO is rich in certain polyphenols: that pleasant peppery “sting” in the back of your throat. The molecule behind it –oleocanthal –was identified in the 1990s/2000s and named for its olive origin (oleo-), sting (-canth-), and aldehyde groups (-al) (7,8,9). At the molecular level, oleocanthal inhibits COX-1 and COX-2, the same pathways targeted by ibuprofen, offering a biologically plausible route to dampen inflammation, a driver of many cancers (8,10).

 

How Polyphenols May Help Protect Against Cancer

Scientists have mapped several anti-cancer “levers” influenced by olive oil polyphenols:

Taming inflammation & growth signals. 

  • Laboratory work shows EVOO polyphenols can slow cancer cell proliferation, promote apoptosis (programmed cell death), and inhibit pathways cancers use to grow and spread (10,14).

Cutting off blood supply (anti-angiogenesis).

  • Oleocanthal and oleacein reduced endothelial cell proliferation, invasion, and tube formation in experimental models – steps tumors need to build new blood vessels (15).

Targeting cancer cell weak spots.

  • Oleocanthal-rich EVOO has been shown to damage cancer cell lysosomes (the cell’s recycling center), selectively triggering cancer cell death in vitro and reducing tumor burden in mice – effects not seen with oleocanthal-poor oils (28).

Supporting the gut-immune axis. 

  • The gut microbiome – a key regulator of immunity and inflammation – appears to shift favorably with olive oil–rich diets, including IgA-related mucosal immunity changes with phenol-enriched EVOO (16,17,22,25). These shifts may help lower systemic inflammation and influence cancer-relevant pathways.

None of this means olive oil “treats” cancer on its own, but it gives strong biological rationale for why regular intake of high-phenolic EVOO may support lower risk and better long-term outcomes.

 

Olive Oil vs. Most Common Cancers in US

Olive Oil and Breast Cancer

  • In the PREDIMED trial’s secondary analysis, women advised to eat a Mediterranean diet plus EVOO had lower rates of invasive breast cancer than controls over ~5 years (32).

  • Mechanistically, oleocanthal has been shown to block c-Met signaling (a pathway tied to tumor invasion and metastasis), suppress proliferation and invasiveness, and slow tumor growth in models (33).

  • In mouse studies, daily oral oleocanthal reduced triple-negative breast cancer growth and lowered recurrence after primary tumor removal; it also modulated markers connected to tumor aggressiveness and enhanced tamoxifen sensitivity in ER+ models (34,35).

  • Other work shows oleocanthal can inhibit mTOR, a central growth hub commonly overactive in cancers (36), and demonstrates broader anti-angiogenic and anti-invasion actions in breast and prostate cell lines (37,38).

Olive Oil and Prostate Cancer

  • Prostate cancer is the second most common cancer in men (39). Emerging preclinical data suggest oleocanthal can target SMYD2, an enzyme implicated in aggressive, metastatic castration-resistant prostate cancer (mCRPC), reducing cancer cells viability, migration, invasion, and colony formation, and lowering PSA in mouse models (40).

  • Both pure oleocanthal as well as oleocanthal-rich olive oils were shown to cause rupture of prostate cancer cells lysosomes and significantly inhibit their growth and proliferation (28).

  • Purified olive oil polyphenols have also shown anti-proliferative and anti-migration effects in prostate cell lines, which suggest activity that might prevent tumor expansion and metastasis (42).

Olive Oil and Colon (colorectal) Cancer

  • Colorectal cancer is the third most common non-skin cancer in U.S. men and women (43). Chronic inflammation is a major driver, and COX-2 over-expression is common and linked to poorer prognosis – consistent with the protective signals seen for NSAIDs (like ibuprofen) in large human studies (44–47).

  • Oleocanthal has shown anti-tumor effects in liver and colon cancer cells – reducing viability, triggering apoptosis, and inhibiting colony formation, in some models even outperforming ibuprofen while sparing healthy cells (14).

  • EVOO extracts rich in hydroxytyrosol, secoiridoids, and lignans reduced proliferation in colon cancer models, with evidence that phenols can interact with estrogen receptor-β to modulate growth (49).

  • Hydroxytyrosol specifically can accelerate EGFR degradation, dialing down a pathway often upregulated in colorectal tumors (50).

  • Reviews of diet–microbiome–cancer triads highlight olive oil polyphenols’ plausible roles in lowering oxidative stress and inflammation and modulating epigenetics—all relevant to colorectal cancer prevention (51).

How Much Olive Oil Should I Use?

  • Science-Backed Daily Intake:. EFSA’s authorized claim is tied to phenolic compounds at levels typically delivered by ~20 g (≈1.5 Tbsp) of high-phenolic EVOO per day (6).

  • Make Smart Swaps: The U.S. cohort data suggest replacing 10 g/day of butter, margarine, mayonnaise, or dairy fat with olive oil is associated with meaningfully lower mortality—including from cancer (4).

  • Quality Matters: Polyphenol content varies widely between oils; peppery, robust oils are often richer in oleocanthal and friends (7–10).

  • With Food or Straight? There isn’t definitive human evidence that timing or co-ingestion changes outcomes; the priority is consistent daily intake as part of an overall Mediterranean-style pattern (6).

  • About “mega-doses.” One human trial using phenol-enriched EVOO noted shifts in intestinal immune markers alongside a bump in CRP—a reminder that very high isolated doses may behave differently than culinary-level intake within a varied, polyphenol-rich diet (22).

Bottom line for your kitchen (and your health)

The modern evidence base – epidemiology, clinical data, and plausible lab mechanisms – points in the same direction: making extra virgin olive oil, especially high-phenolic EVOO, your everyday fat is a smart move for long-term health. While no single food can “prevent” cancer, EVOO’s polyphenols (notably oleocanthal, oleacein, and hydroxytyrosol) touch multiple biology “switches” linked to cancer development and progression. Pair that with a Mediterranean-style plate, regular movement, and other lifestyle pillars, and you’re stacking the deck in your favor (1–6,14–17,22,25,28,32–36,39–47,49–51).

This article is for educational purposes only and isn’t medical advice. If you’re navigating cancer risk or treatment, talk with your care team about how to tailor diet—including EVOO—to your plan.


FAQ: Olive Oil and Cancer

Does olive oil kill cancer cells? 

High-phenolic extra virgin olive oil (EVOO) contains compounds—especially oleocanthal and oleacein—that have been shown in lab, animal, and early human research to damage or kill certain cancer cells while sparing healthy cells. It’s not a cure, but it’s a promising dietary ally.

Can cancer patients take olive oil?

Generally, yes—as part of a balanced diet and with your care team’s guidance. High-phenolic EVOO is food, and emerging evidence suggests potential benefits; it should complement, not replace, treatment.

What is the number one cancer fighting food?

There’s no single “#1” food. Evidence favors a Mediterranean-style pattern—and within it, high-phenolic EVOO stands out for anti-inflammatory and antioxidant activity linked to lower cancer risk. 

What oils fight cancer cells?

High-phenolic extra virgin olive oil shows the strongest evidence, driven by oleocanthal and oleacein—compounds that can inhibit proliferation, trigger apoptosis, and block tumor angiogenesis in models. 

Does olive oil lose its health benefits when heated?

No, not entirely. Some antioxidants decline with heat, but cooking with EVOO can increase the phenols you actually consume because foods absorb olive-oil polyphenols.


References

(1) WHO Cancer. https://www.who.int/news-room/fact-sheets/detail/cancer (accessed 2024-02-22).
(2) Buckland, G. et al. Adherence to the Mediterranean Diet and Risk of Breast Cancer… Int. J. Cancer 2013, 132 (12), 2918–2927. https://doi.org/10.1002/ijc.27958.
(3) Psaltopoulou, T. et al. Olive Oil Intake Is Inversely Related to Cancer Prevalence… Lipids Health Dis. 2011, 10, 127. https://doi.org/10.1186/1476-511X-10-127.
(4) Guasch-Ferré, M. et al. Consumption of Olive Oil and Risk of Total and Cause-Specific Mortality… J. Am. Coll. Cardiol. 2022, 79 (2), 101–112. https://doi.org/10.1016/j.jacc.2021.10.041.
(5) Romani, A. et al. Health Effects of Phenolic Compounds Found in Extra-Virgin Olive Oil… Nutrients 2019, 11 (8), 1776. https://doi.org/10.3390/nu11081776.
(6) Polyphenols in olive related health claims | EFSA. https://www.efsa.europa.eu/en/efsajournal/pub/2033 (accessed 2024-02-22).
(7) Montedoro, G. et al. Simple and Hydrolyzable Compounds in Virgin Olive Oil… J. Agric. Food Chem. 1993, 41 (11), 2228–2234. https://doi.org/10.1021/jf00035a076.
(8) Beauchamp, G. K. et al. Phytochemistry: Ibuprofen-like Activity in Extra-Virgin Olive Oil. Nature 2005, 437 (7055), 45–46. https://doi.org/10.1038/437045a.
(9) Cicerale, S. et al. Sensory Characterization of the Irritant Properties of Oleocanthal… Chem. Senses 2009, 34 (4), 333–339. https://doi.org/10.1093/chemse/bjp006.
(10) Pang, K.-L.; Chin, K.-Y. The Biological Activities of Oleocanthal… Nutrients 2018, 10 (5), 570. https://doi.org/10.3390/nu10050570.
(14) Cusimano, A. et al. Oleocanthal Exerts Antitumor Effects on Human Liver and Colon Cancer Cells… Int. J. Oncol. 2017, 51 (2), 533–544. https://doi.org/10.3892/ijo.2017.4049.
(15) Marrero, A. D. et al. Anti-Angiogenic Effects of Oleacein and Oleocanthal… Biomed. Pharmacother. 2023, 165, 115234. https://doi.org/10.1016/j.biopha.2023.115234.
(16) Mills, S. et al. Precision Nutrition and the Microbiome… Nutrients 2019, 11 (4), 923. https://doi.org/10.3390/nu11040923.
(17) Gavahian, M. et al. Health Benefits of Olive Oil and Its Components… Trends Food Sci. Technol. 2019, 88, 220–227. https://doi.org/10.1016/j.tifs.2019.03.008.
(22) Martín-Peláez, S. et al. Influence of Phenol-Enriched Olive Oils on Human Intestinal Immune Function. Nutrients 2016, 8 (4), 213. https://doi.org/10.3390/nu8040213.
(25) Millman, J. F. et al. Extra-Virgin Olive Oil and the Gut-Brain Axis… Nutr. Rev. 2021, 79 (12), 1362–1374. https://doi.org/10.1093/nutrit/nuaa148.
(28) Goren, L. et al. (-)-Oleocanthal and (-)-Oleocanthal-Rich Olive Oils Induce Lysosomal Membrane Permeabilization… PLOS ONE 2019, 14 (8), e0216024. https://doi.org/10.1371/journal.pone.0216024.
(29) El Haouari, M.; Quintero, J. E.; Rosado, J. A. Anticancer Molecular Mechanisms of Oleocanthal. Phytother. Res. 2020, 34 (11), 2820–2834. https://doi.org/10.1002/ptr.6722.
(32) Toledo, E. et al. Mediterranean Diet and Invasive Breast Cancer Risk… JAMA Intern. Med. 2015, 175 (11), 1752–1760. https://doi.org/10.1001/jamainternmed.2015.4838.
(33) Akl, M. R. et al. Olive Phenolics as C-Met Inhibitors… PLOS ONE 2014, 9 (5), e97622. https://doi.org/10.1371/journal.pone.0097622.
(34) Siddique, A. B. et al. (-)-Oleocanthal Prevents Breast Cancer Locoregional Recurrence… Cancers 2019, 11 (5), 637. https://doi.org/10.3390/cancers11050637.
(35) Ayoub, N. M. et al. The Olive Oil Phenolic (-)-Oleocanthal Modulates Estrogen Receptor… Eur. J. Pharmacol. 2017, 810, 100–111. https://doi.org/10.1016/j.ejphar.2017.06.019.
(36) Khanfar, M. A. et al. Olive Oil-Derived Oleocanthal as Potent Inhibitor of mTOR… Phytother. Res. 2015, 29 (11), 1776–1782. https://doi.org/10.1002/ptr.5434.
(37) Thieme E-Journals - Planta Medica / Abstract. https://www.thieme-connect.de/products/ejournals/abstract/10.1055/s-0030-1270724 (accessed 2024-02-22).
(38) Qusa, M. H. et al. Comparative Gene Signature of (-)-Oleocanthal Formulation Treatments… Nutrients 2021, 13 (5), 1706. https://doi.org/10.3390/nu13051706.
(39) Key Statistics for Prostate Cancer | Prostate Cancer Facts. https://www.cancer.org/cancer/types/prostate-cancer/about/key-statistics.html (accessed 2024-02-22).
(40) Siddique, A. B. et al. Oleocanthal Attenuates Metastatic Castration-Resistant Prostate Cancer… Cancers 2022, 14 (14), 3542. https://doi.org/10.3390/cancers14143542.
(41) Baci, D. et al. Downregulation of Pro-Inflammatory and Pro-Angiogenic Pathways… Int. J. Mol. Sci. 2019, 20 (2), 307. https://doi.org/10.3390/ijms20020307.
(42) León-González, A. J. et al. Comparative Cytotoxic Activity of Hydroxytyrosol and Its Semisynthetic… Antioxidants 2021, 10 (9), 1348. https://doi.org/10.3390/antiox10091348.
(43) Colorectal Cancer Statistics | How Common Is Colorectal Cancer? https://www.cancer.org/cancer/types/colon-rectal-cancer/about/key-statistics.html (accessed 2024-02-22).
(44) Terzić, J. et al. Inflammation and Colon Cancer. Gastroenterology 2010, 138 (6), 2101-2114.e5. https://doi.org/10.1053/j.gastro.2010.01.058.
(45) Marnett, L. J.; DuBois, R. N. COX-2: A Target for Colon Cancer Prevention. Annu. Rev. Pharmacol. Toxicol. 2002, 42 (1), 55–80. https://doi.org/10.1146/annurev.pharmtox.42.082301.164620.
(46) Piazuelo, E.; Lanas, A. NSAIDS and Gastrointestinal Cancer. Prostaglandins Other Lipid Mediat. 2015, 120, 91–96. https://doi.org/10.1016/j.prostaglandins.2015.06.001.
(47) Ghanghas, P. et al. Chemopreventive Action of Non-Steroidal Anti-Inflammatory Drugs… Biomed. Pharmacother. 2016, 78, 239–247. https://doi.org/10.1016/j.biopha.2016.01.024.
(49) Pampaloni, B. et al. In Vitro Effects of Extracts of Extra Virgin Olive Oil on Human Colon Cancer Cells. Nutr. Cancer 2014, 66 (7), 1228–1236. https://doi.org/10.1080/01635581.2014.951727.
(50) Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing EGFR degradation… Mol. Nutr. Food Res. https://onlinelibrary.wiley.com/doi/10.1002/mnfr.201500498 (accessed 2024-02-22).
(51) Memmola, R. et al. Correlation between Olive Oil Intake and Gut Microbiota in Colorectal Cancer Prevention. Nutrients 2022, 14 (18), 3749. https://doi.org/10.3390/nu14183749.

 

Who's behind kyoord?

The founder of kyoord, Dr. Limor Goren is a cancer researcher and molecular biologist. Dr. Goren discovered one of the mechanisms by which Oleocanthal - an anti-inflammatory molecule found in EVOO - is toxic to cancer and showed that oleocanthal-rich olive oils is an effective strategy to kill various types of cancer cells.

LEARN MORE